• OliX Pharmaceuticals granted stock options covering 45,000 common shares to two executives on Nov. 13, 2026.
• A non-registered executive received options covering 30,000 shares; an affiliate executive received options covering 15,000 shares.
• The options are exercisable from Nov. 14, 2029, through Nov. 13, 2034, at KRW 89,300 per share.
• Exercises will be settled through newly issued shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OliX Pharmaceuticals Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261113001225), on November 13, 2026, and is solely responsible for the information contained therein.